How to predict the presence of cardiac amyloidosis in patients with atrial fibrillation

被引:0
作者
Kataoka, Naoya [1 ]
Imamura, Teruhiko [1 ]
机构
[1] Univ Toyama, Dept Internal Med 2, 2630 Sugitani, Toyama, Toyama 9300194, Japan
关键词
Arrhythmia; Catheter ablation; Heart failure; Cardiomyopathy;
D O I
10.1007/s00380-024-02501-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:557 / 557
页数:1
相关论文
共 3 条
[1]   Prevalence of cardiac amyloidosis in atrial fibrillation: a CMR study prior to catheter ablation [J].
Azuma, Mai ;
Kato, Shingo ;
Sawamura, Shungo ;
Fukui, Kazuki ;
Takizawa, Ryouya ;
Nakayama, Naoki ;
Ito, Masanori ;
Hibi, Kiyoshi ;
Utsunomiya, Daisuke .
HEART AND VESSELS, 2025, 40 (02) :131-139
[2]   Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review [J].
Bukhari, Syed ;
Khan, Syed Zamrak ;
Bashir, Zubair .
JOURNAL OF CARDIAC FAILURE, 2023, 29 (01) :76-86
[3]   Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis [J].
Griffin, Jan M. ;
Rosenblum, Hannah ;
Maurer, Mathew S. .
CIRCULATION RESEARCH, 2021, 128 (10) :1554-1575